Search all trials

Find therapies in clinical trials near you

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

HIV infection

Recruiting

Registered drugNo placebo

Cabotegravir and Rilpivirine Ultra‑Long‑Acting vs Long‑Acting in Adults and Adolescents with HIV Who Are Virally Suppressed

Registered drugNo placebo

Spain

Participants:0–17 years · 18–64 years · 65+ years
Substances:Cabotegravir

Contact Research Centre

HIV infection

Recruiting

Registered drugNo placebo

Switching to Lenacapavir, Teropavimab, and Zinlirvimab in Virologically Suppressed Adults with HIV-1: A Phase 3 Randomized Study

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Abacavir

Contact Research Centre

HIV infection

Recruiting

Registered drugNo placebo

Switching to Lenacapavir-based drug combination vs cabotegravir-based drug combination in virologically suppressed adults with HIV-1

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Cabotegravir

Contact Research Centre

HIV infection

Recruiting

Registered drugNo placebo

A study to evaluate the effectiveness of lenalidomide, pyrimethamine, and topiramate in reducing the HIV reservoir in people living with HIV.

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Lenalidomide

Contact Research Centre

HIV infection

Recruiting

Registered drug

A study of islatravir and ulonivirine for adults with HIV who have not received previous treatment

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Emtricitabine

Contact Research Centre

HIV infection

Recruiting

Registered drugNo placebo

A study testing VH4524184 with emtricitabine and tenofovir alafenamide compared to dolutegravir and lamivudine in adults with HIV-1 who have not received treatment before

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Dolutegravir Sodium

Contact Research Centre

HIV infection

Recruiting

Registered drugNo placebo

A Study of Venetoclax in People with HIV-1 Infection Starting Antiretroviral Treatment to Reduce the HIV Reservoir

Registered drugNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:Venetoclax

Contact Research Centre

HIV infection

Recruiting

Registered drugNo placebo

Study of pneumococcal vaccines in healthy young adults, older adults and people with HIV infection

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years · Healthy volunteers
Substances:Pneumococcal Polysaccharide Serotype 1

Contact Research Centre

HIV infection+1

Recruiting

Registered drug

Study on Colchicine to Reduce Heart Artery Inflammation in HIV Patients Over 50 with High Cardiovascular Risk

Registered drug

Spain

Participants:18–64 years · 65+ years
Substances:Colchicine

Contact Research Centre

HIV infection

Recruiting

Registered drugNo placebo

Study Comparing Doravirine/Lamivudine and Dolutegravir/Lamivudine for HIV Patients with Controlled Viral Load on Three-Drug Regimens

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Dolutegravir

Contact Research Centre

HIV infection+1

Recruiting

Registered drug

Study on the Effectiveness of 10-1074-LS and Teropavimab in Controlling HIV in Patients with Early Stage HIV Infection

Registered drug

Belgium

Participants:18–64 years
Substances:Sodium Chloride

Contact Research Centre

HIV infection

Recruiting

Registered drugNo placebo

Study Comparing Doravirine and Dolutegravir-Based Treatments for People with HIV-1 Who Have Not Yet Started Therapy

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Dolutegravir Sodium

Contact Research Centre

Find therapies in clinical trials near you

75 trials match your criteria

HIV infection

Cabotegravir and Rilpivirine Ultra‑Long‑Acting vs Long‑Acting in Adults and Adolescents with HIV Who Are Virally Suppressed

HIV infection

Switching to Lenacapavir, Teropavimab, and Zinlirvimab in Virologically Suppressed Adults with HIV-1: A Phase 3 Randomized Study

HIV infection

Switching to Lenacapavir-based drug combination vs cabotegravir-based drug combination in virologically suppressed adults with HIV-1

HIV infection

A study to evaluate the effectiveness of lenalidomide, pyrimethamine, and topiramate in reducing the HIV reservoir in people living with HIV.

HIV infection

A study of islatravir and ulonivirine for adults with HIV who have not received previous treatment

HIV infection

A study testing VH4524184 with emtricitabine and tenofovir alafenamide compared to dolutegravir and lamivudine in adults with HIV-1 who have not received treatment before

HIV infection

A Study of Venetoclax in People with HIV-1 Infection Starting Antiretroviral Treatment to Reduce the HIV Reservoir

HIV infection

Study of pneumococcal vaccines in healthy young adults, older adults and people with HIV infection

HIV infection+1

Study on Colchicine to Reduce Heart Artery Inflammation in HIV Patients Over 50 with High Cardiovascular Risk

HIV infection

Study Comparing Doravirine/Lamivudine and Dolutegravir/Lamivudine for HIV Patients with Controlled Viral Load on Three-Drug Regimens

HIV infection+1

Study on the Effectiveness of 10-1074-LS and Teropavimab in Controlling HIV in Patients with Early Stage HIV Infection

HIV infection

Study Comparing Doravirine and Dolutegravir-Based Treatments for People with HIV-1 Who Have Not Yet Started Therapy

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.